Sr. Specialist, TCS. CN
April 02, 2021
Some common questions that arise frequently are:
- The biologic is very sensitive, can the system provide enough protection?
- The molecules are very complex, can the system maintain stability?
- The timeline for approval is very tight, will the system be approved?
These questions are especially challenging for a company that may have expertise in drug development, but not primary package systems. West can help. Based on extensive knowledge and a history of market leadership, West offers primary packaging systems that can address these and other questions. An example is the Ready Pack™ system, which comprises NovaPure® stoppers, Flip-Off® CCS (clean, certified, sterilized) seals, and Schott adaptiQ® glass vials. In particular, NovaPure stoppers have a FluroTec™ barrier film in areas that contact drug product. This film, based on poly(ethylene tetrafluroethylene), provides added protection by reducing:
- migration of leachables from elastomer into drug product
- interaction of drug products with stoppers
Each NovaPure stopper is vision inspected using the Envision™ verification process to ensure low and controlled particle levels. Ready Pack system components are offered in quantities that support every development stage – from concept through commercialization. They may be a very good choice for biologics and biosimilars. For more information, contact an Account Manager or Technical Customer Service representative.
Ready Pack™, NovaPure®, Flip-Off®, FluroTec™ and Envision™ are trademarks and registered trademarks of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.
adaptiQ® is a registered trademark of Schott AG.